Carola Nicholas, Serotte Jordan Cook, Jung David, Maassen Nicholas H, Shi Lewis
Frank H. Netter School of Medicine, Quinnipiac University, North Haven, Connecticut, U.S.A.
Department of Orthopaedic Surgery, University of Chicago, Chicago, Illinois, U.S.A..
Arthroscopy. 2025 Aug;41(8):3052-3062. doi: 10.1016/j.arthro.2024.11.060. Epub 2024 Nov 22.
To review the current literature regarding the use of bone marrow aspirate concentrate (BMAC) in rotator cuff repair surgery to determine variations in the preparation and administration of BMAC; assess the healing rates with the use of BMAC in terms of postoperative range of motion (ROM), patient-reported outcomes (PROMs), and retear rates; and analyze the safety of using BMAC.
A Preferred Reporting Items for Systematic Reviews and Meta-Analyses compliant search was performed. Two independent authors screened all suitable studies for their inclusion, obtained the data, and assessed risk of bias. The types of studies included in the analysis were human studies of randomized control trials, prospective cohort, case control, and case series.
Seven studies reported PROMs: 4 of 7 studies reported statistically significant improvements in at least 4 different scores, with 2 of 7 studies reporting general improvements in the BMAC groups (with no statistical analysis provided). Of the 2 comparative studies, neither was able to show a difference in PROMs between the control and biologic groups. Postoperative ROM was reported in 5 studies: 3 of 5 studies showed statistically significant improvement in ROM, 1 study showed general improvement (with no statistical analysis provided), and 1 study showed no difference in postoperative ROM between a BMAC and control group. Retear rates were mixed: 1 study reported that rates between the concentrated bone marrow aspirate and control group did not differ (P = .964), while another found that the mesenchymal stem cell augmentation improved healing both short term (6 months) and long-term (10 years). There were no complications associated with the use of BMAC in rotator cuff repairs in any of the studies included.
This systematic review shows that BMAC as an intervention in rotator cuff repair has not been associated with increased complication rates. In the available literature, there is significant heterogeneity among the included studies in terms of study design, patient demographics, surgical techniques, and methods of BMAC preparation and application as well as reported measures and follow-up periods. Some studies suggest that BMAC may enhance healing rates, pain relief, and functional improvements for both short- and long-term outcomes.
Level IV, systematic review of Level I to IV studies.
回顾当前关于在肩袖修复手术中使用骨髓抽吸浓缩物(BMAC)的文献,以确定BMAC制备和应用的差异;从术后活动范围(ROM)、患者报告结局(PROMs)和再撕裂率方面评估使用BMAC的愈合率;并分析使用BMAC的安全性。
进行了一项符合系统评价和Meta分析首选报告项目的检索。两位独立作者筛选所有合适的研究以纳入其中,获取数据并评估偏倚风险。分析中纳入的研究类型包括随机对照试验、前瞻性队列研究、病例对照研究和病例系列的人体研究。
七项研究报告了PROMs:七项研究中的四项报告至少在4种不同评分上有统计学显著改善,七项研究中的两项报告BMAC组有总体改善(未提供统计分析)。在两项比较研究中,均未能显示对照组和生物制剂组之间在PROMs上有差异。五项研究报告了术后ROM:五项研究中的三项显示ROM有统计学显著改善,一项研究显示有总体改善(未提供统计分析),一项研究显示BMAC组和对照组之间术后ROM无差异。再撕裂率情况不一:一项研究报告浓缩骨髓抽吸物组和对照组之间的比率无差异(P = 0.964),而另一项研究发现间充质干细胞增强在短期(6个月)和长期(10年)均改善了愈合。在纳入的任何研究中,肩袖修复中使用BMAC均未出现并发症。
本系统评价表明,BMAC作为肩袖修复的一种干预措施,并未导致并发症发生率增加。在现有文献中,纳入研究在研究设计、患者人口统计学、手术技术、BMAC制备和应用方法以及报告指标和随访期方面存在显著异质性。一些研究表明,BMAC可能提高短期和长期结局的愈合率、缓解疼痛并改善功能。
四级,对一级至四级研究的系统评价。